Tempest Therapeutics, Inc. (TPST) Return on equity
Tempest Therapeutics, Inc. (TPST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-76.0%FY2016
| Fiscal year | Value | YoY |
|---|---|---|
| FY2016 | -76.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net incomeTPST Net marginTPST Gross profitTPST Gross marginTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Total liabilitiesTPST Shareholders’ equityTPST overview →